Zhenlong Ye

1.2k total citations · 1 hit paper
19 papers, 909 citations indexed

About

Zhenlong Ye is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Zhenlong Ye has authored 19 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Zhenlong Ye's work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Zhenlong Ye is often cited by papers focused on CAR-T cell therapy research (8 papers), Virus-based gene therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Zhenlong Ye collaborates with scholars based in China and United States. Zhenlong Ye's co-authors include Qijun Qian, Huajun Jin, Xinchun Li, Xinyue Wang, Liang Cheng, Zhong Li, Changzheng Zhang, Shuo Ma, Yuan Zhuang and Zhen-Gang Yuan and has published in prestigious journals such as Frontiers in Immunology, Advances in experimental medicine and biology and International Immunopharmacology.

In The Last Decade

Zhenlong Ye

19 papers receiving 899 citations

Hit Papers

Current Progress in CAR-T Cell Therapy for Solid Tumors 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current Progress in CAR-T Cell Therapy for Solid Tumors
    2019 358 citations Shuo Ma, Xinchun Li et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenlong Ye China 13 593 342 330 171 162 19 909
Xiuqi Wu China 9 557 0.9× 355 1.0× 299 0.9× 129 0.8× 121 0.7× 13 816
Huajun Jin China 15 414 0.7× 238 0.7× 321 1.0× 93 0.5× 171 1.1× 27 731
Leo D. Wang United States 13 396 0.7× 330 1.0× 336 1.0× 139 0.8× 116 0.7× 25 924
Haiyan Xing China 22 626 1.1× 380 1.1× 591 1.8× 108 0.6× 153 0.9× 85 1.2k
Yunxin Lai China 9 504 0.8× 250 0.7× 227 0.7× 175 1.0× 101 0.6× 10 779
Huiping Gao China 12 616 1.0× 392 1.1× 248 0.8× 142 0.8× 90 0.6× 22 889
Erhao Zhang China 13 410 0.7× 173 0.5× 356 1.1× 114 0.7× 97 0.6× 18 725
Bruno L. Cadilha Germany 10 945 1.6× 560 1.6× 393 1.2× 277 1.6× 183 1.1× 16 1.3k
Parisa Malekzadeh United States 7 651 1.1× 377 1.1× 196 0.6× 150 0.9× 101 0.6× 14 795

Countries citing papers authored by Zhenlong Ye

Since Specialization
Citations

This map shows the geographic impact of Zhenlong Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlong Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlong Ye more than expected).

Fields of papers citing papers by Zhenlong Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenlong Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlong Ye. The network helps show where Zhenlong Ye may publish in the future.

Co-authorship network of co-authors of Zhenlong Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenlong Ye. A scholar is included among the top collaborators of Zhenlong Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenlong Ye. Zhenlong Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Peng, Ling, Bicheng Zhang, Brian G. Till, et al.. (2022). Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies. Frontiers in Immunology. 13. 882172–882172. 4 indexed citations
2.
Ye, Zhenlong, et al.. (2021). The role of mesenchymal stem cells in liver injury. Cell Biology International. 46(4). 501–511. 15 indexed citations
3.
Zhuang, Yuan, et al.. (2020). Current Progress in CAR-T Cell Therapy for Hematological Malignancies. Journal of Cancer. 12(2). 326–334. 125 indexed citations
4.
Li, Xinchun, et al.. (2020). Strategies for enrichment of circulating tumor cells. Translational Cancer Research. 9(3). 2012–2025. 41 indexed citations
5.
Qiu, Jinrong, Xinchun Li, Zhuo Chen, et al.. (2020). <p>Changes and Clinical Significance of Detailed Peripheral Lymphocyte Subsets in Evaluating the Immunity for Cancer Patients</p>. Cancer Management and Research. Volume 12. 209–219. 6 indexed citations
6.
Huang, Yao, Pinyi Liu, Zhenlong Ye, et al.. (2020). A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer. Molecular Oncology. 14(3). 657–668. 29 indexed citations
7.
Ma, Shuo, Xinchun Li, Xinyue Wang, et al.. (2019). Current Progress in CAR-T Cell Therapy for Solid Tumors. PMC. 2 indexed citations
8.
Ma, Shuo, Xinchun Li, Xinyue Wang, et al.. (2019). Current Progress in CAR-T Cell Therapy for Solid Tumors. International Journal of Biological Sciences. 15(12). 2548–2560. 358 indexed citations breakdown →
9.
Zhuang, Yuan, Changzheng Zhang, Qiong Wu, et al.. (2019). Application of immune repertoire sequencing in cancer immunotherapy. International Immunopharmacology. 74. 105688–105688. 8 indexed citations
10.
Ye, Zhenlong, Yongmei Ding, Zhuo Chen, et al.. (2019). Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies. 2 indexed citations
11.
Zhu, Lina, et al.. (2019). Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing. Journal of Pediatric Endocrinology and Metabolism. 32(3). 295–300. 12 indexed citations
12.
Ye, Zhenlong, Yongmei Ding, Zhuo Chen, et al.. (2018). Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies. Cancer Biology & Therapy. 20(4). 546–551. 34 indexed citations
13.
Ye, Zhenlong, et al.. (2017). Cancer vaccine: learning lessons from immune checkpoint inhibitors. Journal of Cancer. 9(2). 263–268. 33 indexed citations
14.
Ye, Zhenlong, Pinyi Liu, Yao Huang, et al.. (2017). 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity. Journal of Cancer. 8(2). 199–206. 9 indexed citations
15.
Ye, Zhenlong, Yongmei Ding, Linfang Li, et al.. (2017). Mesothelin-targeting chimeric antigen receptor–modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma. Tumor Biology. 39(4). 3726131194–3726131194. 17 indexed citations
16.
Ye, Zhenlong, Li Zhong, Huajun Jin, & Qijun Qian. (2016). Therapeutic Cancer Vaccines. Advances in experimental medicine and biology. 909. 139–167. 13 indexed citations
17.
Zhang, Hao, et al.. (2016). New Strategies for the Treatment of Solid Tumors with CAR-T Cells. International Journal of Biological Sciences. 12(6). 718–729. 76 indexed citations
18.
Ye, Zhenlong, Yao Huang, Linfang Li, et al.. (2015). Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Acta Pharmacologica Sinica. 36(10). 1237–1245. 37 indexed citations
19.
Ye, Zhenlong, Huajun Jin, & Qijun Qian. (2015). Argonaute 2: A Novel Rising Star in Cancer Research. Journal of Cancer. 6(9). 877–882. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuqi Wu Breakdown of academic impact, for papers by Huajun Jin Breakdown of academic impact, for papers by Leo D. Wang Breakdown of academic impact, for papers by Haiyan Xing Breakdown of academic impact, for papers by Yunxin Lai Breakdown of academic impact, for papers by Huiping Gao Breakdown of academic impact, for papers by Erhao Zhang Breakdown of academic impact, for papers by Bruno L. Cadilha Breakdown of academic impact, for papers by Parisa Malekzadeh
Rankless by CCL
2026